Physician profile
Patrick V Solcher
NPI 1851377766
$20,179.04
in general payments reported to CMS, 2019-2025
62 companies · $1,912 in 2025
The $1,912 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,473 · 2020: $3,231 · 2021: $3,338 · 2022: $2,701 · 2023: $2,798 · 2024: $2,726 · 2025: $1,912.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,436.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $2,190.86 | 2019-2025 | Evenity, Repatha, Otezla |
| Novo Nordisk INC | $2,166.89 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,855.10 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $1,497.83 | 2019-2025 | Qulipta, Synthroid, Ubrelvy |
| Lilly USA, LLC | $1,276.78 | 2019-2025 | Mounjaro, Zepbound, Emgality |
| Glaxosmithkline, LLC. | $1,019.64 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astellas Pharma US INC | $972.00 | 2019-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $883.13 | 2019-2025 | |
| Kowa Pharmaceuticals America, INC. | $765.65 | 2019-2024 | Livalo, Seglentis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $738.99 | 2019-2025 | Xifaxan, Trulance |
| Amarin Pharma, INC. | $570.03 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $542.83 | 2022-2024 | Qelbree, Qelbree, Xyosted |
| Boehringer Ingelheim Pharmaceuticals, INC. | $467.10 | 2019-2023 | Jardiance |
| Allergan, INC. | $408.22 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $380.07 | 2019-2020 |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $326.85 | 2019-2023 | Trintellix |
| Novartis Pharmaceuticals Corporation | $326.46 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $301.33 | 2019-2023 | Belsomra, Januvia, Steglujan |
| Exact Sciences Corporation | $275.35 | 2023-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $264.47 | 2019-2022 | |
| Axsome Therapeutics, INC. | $218.85 | 2024-2025 | Auvelity |
| Medicure Pharma INC. | $208.76 | 2020-2023 | Zypitamag |
| Ibsa Pharma INC. | $194.80 | 2019-2024 | Tirosint, Tirosint, Licart |
| Sanofi-Aventis U.S. LLC | $171.71 | 2019-2021 | |
| Amneal Pharmaceuticals LLC | $169.11 | 2021-2025 | Unithroid |
| Antares Pharma, INC. | $166.48 | 2021-2023 | Xyosted, Nocdurna, Tlando |
| Arbor Pharmaceuticals, INC. | $160.05 | 2019-2021 | |
| Eisai INC. | $140.25 | 2019-2021 | |
| Idorsia Pharmaceuticals US INC | $110.70 | 2023-2024 | Quviviq |
| Biohaven Pharmaceutical Holding Company LTD. | $107.09 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $96.18 | 2025 | |
| Verity Pharmaceuticals INC. | $90.64 | 2024-2025 | Tlando |
| Endo Pharmaceuticals INC. | $90.26 | 2019-2020 | |
| Genentech USA, INC. | $88.12 | 2019-2022 | |
| Medtronic, INC. | $87.93 | 2023-2024 | Interstim, Intellis Adaptivestim |
| Biohaven Pharmaceuticals, INC. | $74.48 | 2020-2021 | |
| Radius Health, INC. | $72.10 | 2024-2025 | Tymlos |
| Azurity Pharmaceuticals, INC. | $68.40 | 2022-2025 | Edarbi, Alvesco, Edarbi |
| Inspire Medical Systems, INC. | $56.59 | 2023-2025 | Inspire |
| Adlon Therapeutics L.P. | $55.43 | 2020-2021 | |
| Aytu Biopharma, INC. | $46.67 | 2020-2021 | |
| Tolmar, INC. | $46.43 | 2023-2025 | Jatenzo |
| Almatica Pharma LLC | $39.16 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $38.63 | 2024 | Rexulti |
| Currax Pharmaceuticals LLC | $30.31 | 2023-2025 | Contrave, Onzetra Xsail |
| Seqirus USA INC | $30.20 | 2025 | Fluad, Flucelvax |
| Corium, LLC | $25.61 | 2022 | |
| Acerus Pharmaceuticals Corporation | $24.25 | 2021-2022 | |
| Emd Serono, INC. | $24.09 | 2022 | |
| Medtronic USA, INC. | $22.43 | 2019 | |
| Assertio Therapeutics, INC. | $21.95 | 2019 | |
| Hologic Sales and Service, LLC | $21.44 | 2020 | |
| Horizon Therapeutics Plc | $19.50 | 2023 | Krystexxa |
| Shire North American Group INC | $19.44 | 2019 | |
| Abbott Laboratories | $17.10 | 2022 | |
| Genzyme Corporation | $16.31 | 2021 | |
| Halozyme INC | $13.77 | 2023 | |
| Intra-Sana Laboratories | $13.76 | 2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Sumitomo Pharma America, INC. | $13.71 | 2024 | Gemtesa |
| Cleerly, INC. | $12.79 | 2023 | Cleerly Labs |
| Mylan Specialty L.P. | $12.70 | 2020 | |
| Alfasigma USA, INC. | $11.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Solcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.